mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.007 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.007 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.008 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.39 |
0.01 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |